Patent · US Active

Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders

US8586069B2 · kind B2 · utility

2Cited by

232References

9Claims

0Family size

Assignee

Abbott Cardiovascular Systems, Inc. · US

Inventors

Gordon Stewart · San Francisco, US
Gina Zhang · Calabasas, US
Nancy Kirsten · Redwood City, US
Paul Consigny · San Jose, US
Stephen Dugan · San Francisco, US
Gene Park · Oakland, US
Christopher Feezor · Menlo Park, US
Wouter E. Roorda · Newark, US
Syed Faiyaz Ahmed Hossainy · Fremont, US

Key dates

Filing date	Dec 29, 2005
Grant date	Nov 19, 2013
Priority date	—
Expiry date	Jan 2, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61L2300/45
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Drug-delivery systems such as drug-delivery stents having an anti-proliferative agent such as everolimus and an anti-flammatory agent such as clobetasol are provided. Also disclosed are methods of treating a vascular impairment such as restenosis or vulnerable plaque.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.